NOVO.B.DK

249.45

+0.79%↑

GMAB.DK

1,717

-0.12%↓

HLUNB.DK

37.7

+0.16%↑

AMBUB.DK

70.75

-1.53%↓

ZEAL.DK

297.7

+5.98%↑

NOVO.B.DK

249.45

+0.79%↑

GMAB.DK

1,717

-0.12%↓

HLUNB.DK

37.7

+0.16%↑

AMBUB.DK

70.75

-1.53%↓

ZEAL.DK

297.7

+5.98%↑

NOVO.B.DK

249.45

+0.79%↑

GMAB.DK

1,717

-0.12%↓

HLUNB.DK

37.7

+0.16%↑

AMBUB.DK

70.75

-1.53%↓

ZEAL.DK

297.7

+5.98%↑

NOVO.B.DK

249.45

+0.79%↑

GMAB.DK

1,717

-0.12%↓

HLUNB.DK

37.7

+0.16%↑

AMBUB.DK

70.75

-1.53%↓

ZEAL.DK

297.7

+5.98%↑

NOVO.B.DK

249.45

+0.79%↑

GMAB.DK

1,717

-0.12%↓

HLUNB.DK

37.7

+0.16%↑

AMBUB.DK

70.75

-1.53%↓

ZEAL.DK

297.7

+5.98%↑

Search

Coloplast A-S (Class B)

Fechado

458.4 1.55

Visão Geral

Variação de preço das ações

24h

Atual

Mín

449

Máximo

458.5

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

25.385

61.417

EPS

6.32

Rendimento de Dividendos

4.98

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

4.98%

2.40%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-17B

101B

Abertura anterior

456.85

Fecho anterior

458.4

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

16 de mar. de 2026, 21:37 UTC

Aquisições, Fusões, Aquisições de Empresas

Lensar and Alcon Agree to Terminate Merger

16 de mar. de 2026, 19:06 UTC

Notícias Principais

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 de mar. de 2026, 17:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 de mar. de 2026, 23:46 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

16 de mar. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 de mar. de 2026, 23:37 UTC

Conversa de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 de mar. de 2026, 23:05 UTC

Conversa de Mercado

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 de mar. de 2026, 21:56 UTC

Conversa de Mercado

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 de mar. de 2026, 21:41 UTC

Conversa de Mercado
Notícias Principais

Global Equities Roundup: Market Talk

16 de mar. de 2026, 21:41 UTC

Conversa de Mercado
Notícias Principais

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 de mar. de 2026, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 de mar. de 2026, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 de mar. de 2026, 20:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 de mar. de 2026, 20:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 de mar. de 2026, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

16 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Energy & Utilities Roundup: Market Talk

16 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

16 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

16 de mar. de 2026, 19:53 UTC

Notícias Principais

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 de mar. de 2026, 19:43 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

16 de mar. de 2026, 19:43 UTC

Conversa de Mercado

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 de mar. de 2026, 19:37 UTC

Conversa de Mercado
Notícias Principais

Natural Gas Follows Oil Prices Lower -- Market Talk

16 de mar. de 2026, 19:20 UTC

Notícias Principais

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 de mar. de 2026, 19:17 UTC

Conversa de Mercado
Notícias Principais

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 de mar. de 2026, 19:00 UTC

Conversa de Mercado

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 de mar. de 2026, 18:23 UTC

Conversa de Mercado

LME Restarts Trading After Outage -- Market Talk

16 de mar. de 2026, 17:36 UTC

Notícias Principais

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 de mar. de 2026, 17:19 UTC

Conversa de Mercado

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 de mar. de 2026, 17:14 UTC

Notícias Principais

Trump Ends News Conference

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat